[go: up one dir, main page]

NO20073762L - Visko-supplementsammensetning og fremgangsmater - Google Patents

Visko-supplementsammensetning og fremgangsmater

Info

Publication number
NO20073762L
NO20073762L NO20073762A NO20073762A NO20073762L NO 20073762 L NO20073762 L NO 20073762L NO 20073762 A NO20073762 A NO 20073762A NO 20073762 A NO20073762 A NO 20073762A NO 20073762 L NO20073762 L NO 20073762L
Authority
NO
Norway
Prior art keywords
methods
visco
supplement composition
supplement
composition
Prior art date
Application number
NO20073762A
Other languages
English (en)
Inventor
Joel Rosenblatt
Gouhua Chen
Edwin Chan
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO20073762L publication Critical patent/NO20073762L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)

Abstract

Den foreliggende oppfinnelsen vedrører metoder og depotemulsjonsblandinger for avlevering av viskosupplementer.
NO20073762A 2004-12-23 2007-07-19 Visko-supplementsammensetning og fremgangsmater NO20073762L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63853504P 2004-12-23 2004-12-23
US11/305,939 US20060140988A1 (en) 2004-12-23 2005-12-19 Visco-supplement composition and methods
PCT/US2005/046446 WO2006071694A1 (en) 2004-12-23 2005-12-20 Visco-supplement composition and methods

Publications (1)

Publication Number Publication Date
NO20073762L true NO20073762L (no) 2007-09-14

Family

ID=36169128

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073762A NO20073762L (no) 2004-12-23 2007-07-19 Visko-supplementsammensetning og fremgangsmater

Country Status (14)

Country Link
US (1) US20060140988A1 (no)
EP (1) EP1827376A1 (no)
JP (1) JP2008525471A (no)
KR (1) KR20070091302A (no)
AR (1) AR052182A1 (no)
AU (1) AU2005322231A1 (no)
BR (1) BRPI0519199A2 (no)
CA (1) CA2587388A1 (no)
IL (1) IL184062A0 (no)
MX (1) MX2007007826A (no)
NO (1) NO20073762L (no)
RU (1) RU2007127835A (no)
TW (1) TW200640496A (no)
WO (1) WO2006071694A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60311958T2 (de) * 2003-02-03 2007-11-08 Polaschegg, Hans-Dietrich, Dr. Zusammensetzung zur Prävention von Infektionen durch subkutane Prothesen
UY33517A (es) * 2010-07-19 2012-02-29 Astrazeneca Ab Depósito farmacéutico para 5-fluoro-2-[[(1S)-1-(5-fluoro-2-piridil)etil]amino]-6-[(5-isopropoxi-1H-pirazol-3-il)amino]piridin-3-carbonitrilo?.
WO2013076162A1 (en) 2011-11-21 2013-05-30 Université Libre de Bruxelles Formulations useful in the treatment of osteoarticular diseases
US10245306B2 (en) * 2012-11-16 2019-04-02 Isto Technologies Ii, Llc Flexible tissue matrix and methods for joint repair
WO2015018461A1 (fr) 2013-08-09 2015-02-12 Genbiotech Compositions therapeutiques comprenant d'acide hyaluronique
US10179191B2 (en) 2014-10-09 2019-01-15 Isto Technologies Ii, Llc Flexible tissue matrix and methods for joint repair
MX2017008423A (es) 2014-12-23 2017-10-26 Hoffman Steven Formulaciones transdérmicas.
IT201800007683A1 (it) 2018-07-31 2020-01-31 Altergon Sa Composizioni cooperative sinergiche utili per aumento del tessuto molle, rilascio di farmaco e campi correlati
CA3197170A1 (en) * 2020-09-30 2022-04-07 Tolmar International Limited Biodegradable polymer and solvent compositions and systems for extended storage and delivery of active pharmaceutical ingredients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143724A (en) * 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
ITFI980104A1 (it) * 1998-05-04 1999-11-04 Hibiscus S R L Composizioni stabilizzate contenenti acido ialuronico,loro preparazione ed uso
US7582311B1 (en) * 1999-10-15 2009-09-01 Genentech, Inc. Injection vehicle for polymer-based formulations
EP1370610B1 (en) * 2000-11-28 2008-09-10 Genzyme Corporation Polyalkylene glycol viscosity-enhancing polymeric formulations

Also Published As

Publication number Publication date
AR052182A1 (es) 2007-03-07
BRPI0519199A2 (pt) 2008-12-30
TW200640496A (en) 2006-12-01
AU2005322231A1 (en) 2006-07-06
RU2007127835A (ru) 2009-01-27
US20060140988A1 (en) 2006-06-29
MX2007007826A (es) 2007-07-25
EP1827376A1 (en) 2007-09-05
KR20070091302A (ko) 2007-09-10
WO2006071694A1 (en) 2006-07-06
JP2008525471A (ja) 2008-07-17
CA2587388A1 (en) 2006-07-06
IL184062A0 (en) 2007-10-31

Similar Documents

Publication Publication Date Title
NO20073762L (no) Visko-supplementsammensetning og fremgangsmater
CY1118454T1 (el) Πρωτοτυποι αναστολεις πυρρολιου της αναγωγασης s-νιτροζογλουταθειονης ως θεραπευτικοι παραγοντες
DE602005022914D1 (de) Beschichtungszusammensetzung und verfahren
MY142334A (en) Fertilizer-compatible composition
EA200900828A1 (ru) Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1
CY1113199T1 (el) Σταθεροποιημενες συνθεσεις γλυκοσερεμπροσιδασης
DE602004013563D1 (de) Rantagonisten
MY153424A (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
PH12015500550A1 (en) Anti-notch1 nrr antibodies and methods using same
EA200970337A1 (ru) Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения
DE602007012559D1 (de) H die schleimhaut
EA200971051A1 (ru) Ингибиторы p70 s6 киназы
JO3118B1 (ar) تراكيب وطرق لبروتين c5 المتمم يستهدف الأجسام المضادة
ATE538650T1 (de) Cannabinoid-rezeptor-antagonisten / inverse agonisten zur behandlung von übergewicht
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
IL181271A0 (en) Triazolophthalazine derivatives and pharmaceutical compositions containing the same
EA200970132A1 (ru) Аналоги морфолинила и пирролидинила
EA202192146A1 (ru) Антитела к клаудину 6 и их применение
EP2129672A4 (en) ESTER AND CARBAMATE AZAADAMANTANE DERIVATIVES AND METHODS OF USE
MX373170B (es) Variantes de la familia il-1.
EA200970472A1 (ru) Замещенные пиразолы, композиции, их содержащие, способ получения и применение
UA87335C2 (en) Gel composition of 4-hydroxytamoxifen
MEP34308A (en) Oral formulations of cladribine
MX2009010176A (es) Derivados de aza-adamantano 4-substituidos y metodos de uso de los mismos.
ATE535251T1 (de) Stabile wässrige g-csf-haltige zusammensetzungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application